INTRODUCTION
============

Chronic *Helicobacter pylori* infection causes gastritis and peptic ulceration, which are based on excess oxidative stress and perpetuated inflammation.[@b1-jcp-18-161] More than 50% of the world's population is infected by this bacterium. Though the most are apart from risk, but a portion of patients are associated with peptic ulcer disease and its complication[@b2-jcp-18-161] and evidence that *H. pylori* infection is strongly associated with the development of stomach cancer is widely accepted.[@b3-jcp-18-161] Though the chronic infection by *H. pylori* generates a state of inflammation, majority of the subjects remain asymptomatic through their life.[@b2-jcp-18-161] Nonetheless, in a subset of the *H. pylori*-infected population the gastric inflammation may evolve toward chronic active gastritis, and be implicated in more severe gastric diseases such as chronic atrophic gastritis and intestinal metaplasia, known as a precursor of gastric carcinogenesis, peptic ulcers, mucosa-associated lymphoid tissue lymphoma, and gastric cancer. Irrespective of outcomes, the shared features are the ability of *H. pylori* to infect and live persistently in the human stomach eliciting a chronic inflammatory response, which may contribute to a role in determining the varied clinical outcomes of infection. In spite of the report that prophylactic eradication of *H. pylori* after endoscopic resection of early gastric cancer should be used to prevent the development of metachronous gastric carcinoma[@b4-jcp-18-161] and debates still exist, in general case of gastric cancer, the simple removal of the *H. pylori* etiological factor did not contribute to cancer prevention, but can attenuate the emergence of precancerous lesion. Therefore, still more information regarding the link between *H. pylori* infection and gastric cancer according to chronic inflammation is required for advancement of our knowledge in this field.

Extracts of the whole herb of *Artemisia* had been used in traditional oriental medicine to treat inflammation and to accelerate regeneration as well as food component based on its good flavor. Since an ethanol extract of *Artemisia* was reported to possess anti-oxidative and anti-inflammatory effects in various experiments and to exhibit cytoprotective effects against experimentally induced gastrointestinal, hepatic and pancreatic damage, their formulated pills come to clinic for the treatment of inflammation based diseases such as gastritis and colitis.[@b5-jcp-18-161],[@b6-jcp-18-161] The preclinical facts that the ethanol extracts of *Artemisia* very effectively ameliorated the severity of trinitrozobenzoic acid (TNBS)-induced colitis through either inhibition of reactive oxygen species generation or down-regulation of pro-inflammatory signaling as well as significant protection from reflux esophagitis[@b6-jcp-18-161] and various irritants-induced gastric damages.[@b7-jcp-18-161] The discovery of an acidic polysaccharide fraction from the root of *Panax ginseng* C.A. Meyer (Araliaceae) which inhibited *H. pylori* adherence tohost cells was based on hemagglutinating activities.[@b8-jcp-18-161] Woo and colleagues[@b9-jcp-18-161] have reported the acidic polysaccharides from *Artemisia capillaris* inhibited the adhesion of *H. pylori* to host cells via development of the method that quantitated the inhibition of *H. pylori* binding to carbohydrate epitopes present on the glycoprotein via conjugating with peroxidase. Since several phytochemicals or drugs have been used in attempts to decrease *H. pylori*-associated gastric inflammation,[@b10-jcp-18-161] the acidic polysaccharides from *Artemisia capillaris* could be one of the candidates to attenuate *H. pylori*-induced gastric epithelial injury. Therefore, in the present study,we examined the preotective effects of the acidic polysaccharide from *A. capillaris* by measuring *H. pylori*-induced pro-inflammatory signaling molecules on rat gastric mucosa RGM-1 cells under the comparison between the polysaccharide from *Panax ginseng* and green tea.

MATERIALS AND METHODS
=====================

1.. Reagents
------------

All chemical reagents were obtained from Sigma (St. Louis, MO, USA). The polysaccharide fractions from *Artemisia capillaris* (MP), *Panax ginseng* (GP), green tea (GT) and the mixture of GP and MP (MPG6) were provided by S&D Co., Ltd. (Yeongi, Korea). Western blotting detection reagents were obtained from Amersham Biotechnology (Bucks, UK). Primers for RT-PCR were synthesized by Bioneer (Daejeon, Korea). Reverse transcriptase was from Promega (Madison, WI, USA). Antibodies cyclooxygenase-2 (COX-2), cleaved caspase-3, Bcl-2, and PARP were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).

2.. Bacteria culture
--------------------

*H. pylori* strain ATCC 43504 (American Type Culture Collection, a *cagA*^+^ and *vacA* s1-m1 type's strain) for *in vitro* model and Sydney Strain (SS1, a *cagA*^+^, *vacA* s2-m2 strain) for *in vivo* model were used in this study. *H. pylori* were cultured at 37°C in BBL Trypticase Soy (TS) Agar plate with 5% sheep blood (TSA II; BD Biosciences, Franklin Lakes, NJ, USA) under microaerophilic condition (BD GasPaK EZ Gas Generating Systems, BD Biosciences) for 3 days. The bacteria were harvested in clean TS broth, centrifuged at 3000×g for 5 min, and resuspended in broth at a final concentration of 10^9^ colony-forming units (CFUs)/ml. In all experiments, cultures grown for 48 h on TS agar plates were used.

3.. Cell culture and cytotoxicity assay
---------------------------------------

The rat gastric mucosal cells, RGM1, were kindly given by Prof. Hirofumi Matsui (University of Tsukuba, Japan) and human gastric cancer cells, MKN-28 cells were purchased from ATCC (Manassas, VA, USA). Cells were maintained at 37°C in a humidified atmosphere containing 5% CO~2~ and cultured in Dulbecco's modified Eagle's medium containing 10% (v/v) fetal bovine serum and 100 U/ml penicillin. Cell cytotoxicity was measured by MTT \[3-(4, 5-dimethy-lthiazol-2-yl)-2, 5-diphenyltetrazolium bromide\] assay.

4.. RT-PCR
----------

This assay was performed as previously described. After incubation, media was removed by suction and cells were washed with PBS twice. Trizol (Invitrogen) was added to plates, which were then incubated for 10 min at 4°C. Trizol was harvested and placed in a 1.5 ml tube, and 100 *μ*l chloroform (Merck) was added and gently mixed. After incubation for 10 min in ice, samples were centrifuged at 10,000 g for 30 min. Supernatants were extracted and mixed with 200 *μ*l isopropanol (Merck), and mixtures were incubated at 4°C for 1 h. After centrifuging at 13,000 g for 30 min, pellets were washed with 70% (v/v) ethanol. After allowing the ethanol to evaporate completely, pellets were dissolved in 40*μ*l of DEPC-treated water (Invitrogen). cDNA was prepared using reverse transcriptase originating from Murine-Moloney leukemia virus (Promega), according to the manufacturer's instructions. PCR was performed over 25 cycles of: 94°C for 20 s, 55°C for 30 s, and 72°C for 45 s. Oligonucleotide primers designed by authors using NCBI/primer-blast. Oligonucleotide primers were purchased from Bioneer (Daejeon, Korea). Oligonu-cleotide primers were as follows; for COX-2, sense 5′-GAA ATG GCT GCA GAG TTG AA-3′, antisense 5′-TCA TCT AGT CTG GAG TGG GA-3′, for iNOS, sense 5′-TTT TCC CAG GCA ACC AGA CG-3′, antisense 5′-GTA GCG GGG CTT CAG AAT GG-3′, for IL-8, sense 5′-CTC AAG ACC TTC AGC TCC AA-3′, antisense 5′-TTC TCA TAG GAG TCC AGG TG-3′and for VEGF, sense 5′-AAG AGA CTT CCA GCC AGT TG-3′, antisense 5′-TGG ATG GTC TTG GTC CTT AG-3′, and for GAPDH.

5.. Western blot analysis
-------------------------

This assay was performed as previously described. Briefly, treated cells were washed twice with PBS and then lysed in ice-cold cell lysis buffer (Cell Signaling Technology, MA, USA) containing 1 mM PMSF. After 1 h of incubation, samples were centrifuged at 12,000 g for15 min. Supernatants were then collected. Proteins were separated by SDS-PAGE and transferred to polyvinylidene fluoride (PVDF) membranes, which were incubated with appropriate antibodies and visualized using an enhanced chemiluminescence (ECL) system (GE Healthcare, Bucking-hamshire, UK).

6.. Statistical analysis
------------------------

Results are expressed as the mean±SD. The data were analyzed by one-way ANOVA, and the statistical significance between groups was determined by Duncan's multiple range test. Statistical significance was accepted at P\<0.05.

RESULTS
=======

1.. The acidic polysaccharide fractions of *Artemisia capillaris*, *Panax ginseng* and green tea attenuated the inflammatory signaling induced by *H. pylori* infection
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------

RGM-1 cells cultured with the acidic polysaccharides at the concentrations (0, 0.01, 0.1, 1 mg/ml) for 24 h. As seen in [Fig. 1](#f1-jcp-18-161){ref-type="fig"}, there was no change in cell viability up to 1 mg/ml concentration, suggesting the polysaccharides from *Artemisia capillaris, Panax ginseng* and green tea have no cytotoxicity in the gastric mucosal cells. To compare the anti-inflammatory effects of the polysaccharides on *H. pylori*-induced inflammation in RGM-1 cells, the inflammatory mediators were investigated. *H. pylori* infection is associated with robust induction of inflammatory mediators including COX-2 and iNOS.[@b1-jcp-18-161] COX-2 is one of core mediator involved in either *H. pylori*-associated gastritis or carcinogenesis, by which several drugs or strategy had been tried to prevent various gastrointestinal cancers including *H. pylori*-associated gastric tumorigenesis using COX inhibitors. iNOS also has been reported to be engaged in either *H. pylori*-associated gastritis and carcinogensis as evidence that iNOS knock-out mice was resistant to these pathologies of *H. pylori* infection. IL-8 is another important chemokines strongly associated with pathogenesis of *H. pylori* infection. Among the inflammatory mediators, IL-8 plays a crucial role in initiating inflammatory response by chemoattracting and activating neutrophils to the *H. pylori*-infected gastric mucosa.[@b11-jcp-18-161] As expected, 10 MOI of *H. pylori*-stimulated RGM-1 cells increased the expression of the inflammation-associated enzymes, iNOS and COX-2, and the representative cytokines IL-8, as determined by RT-PCR and these increases were significantly inhibited by treatment with the GP, MP, MPG6 and GT ([Fig. 2A](#f2-jcp-18-161){ref-type="fig"}). Since enhanced angiogenic activations in *H. pylori* infection had been highly implicated in either inflammation perpetuation or gastric carcinogenesis,[@b12-jcp-18-161] we have extended the elucidation of the changes of the expressions of angiogenic markers. As seen in [Fig. 2B](#f2-jcp-18-161){ref-type="fig"}, *H. pylori* infection highly induced the mRNA expressions of angiogenic markers including VEGF, HIF-1*α*, platelet-derived growth factor (PDGF), one of the growth factors that plays key role in blood vessel formation, basic fibroblast growth factor (bFGF), one of the growth factors implicated in either cell growth or angiogenesis, inter-cellular adhesion molecule-1 (ICAM-1, well-known as CD54) and vascular cell adhesion protein 1 (VCAM1). However, these increases associated with *H. pylori* infection were all significantly decreased with polysaccharides GP, MP, MPG6 and GT ([Fig. 2B](#f2-jcp-18-161){ref-type="fig"}). To compare the anti-inflammatory effects of the four polysaccharides, the protein levels of COX-2 were investigated. As shown in [Fig. 2C](#f2-jcp-18-161){ref-type="fig"}, the polysaccharides from *A. capillaries* (MP and MPG6) and *Panax ginseng* (GP) significantly inhibited the expression of COX-2 induced by *H. pylori*. However, the polysaccharides from green tea had no inhibitory effect on the protein level of COX-2 induced by *H. pylori*. The reduction of these angiogenic factors with the acidic polysaccharides administration suggested that *H. pylori*- associated chronic inflammation were associated with increased angiogenesis but the polysaccharides, especially from *A. capillaris* significantly attenuated these inevitable gastric cell damage provoked by *H. pylori* infection.

To confirm the findings from *H. pylori*-treated RGM-1 cells, the gastric cancer cell line MKN-28 was used. As expected, the polysaccharides from *A. capillaries,* MP and MPG6 significantly inhibited the expression of COX-2, IL-8 and iNOS induced by *H. pylori* in MKN-28 cells ([Fig. 3A and B](#f3-jcp-18-161){ref-type="fig"}). The treatment with MPG6, the mixture of MP and GP showed much more inhibitory effect on the COX-2 expression than the treatment with MP only in *H. pylori*-infected gastric cancer cells.

2.. The acidic polysaccharide fractions of *Artemisia capillaris* restored the apoptosis induced by *H. pylori* infection
-------------------------------------------------------------------------------------------------------------------------

As *H. pylori* can cause very diverse clinical outcomes, including neoplasms in some individuals, in others atrophy, and in most an unaltered tissue mass, attention has recently been paid to examining the effect of *H. pylori* on the balance between gastric epithelial cell apoptosis and proliferation. Numerous evidences for the induction of apoptosis by *H. pylori* has been obtained in various models including cultured gastric epithelial cells *in vitro*.[@b13-jcp-18-161] It hasreported the role of the Bcl-2 family in the decision step of *H. pylori* induced apoptosis as Bcl-2 and its related family members control a key downstream common cell cycle checkpoint, beyond which apoptosis is inevitable.[@b14-jcp-18-161] Western blot analysis revealed that cleaved caspase-3 was significantly increased andthe expressions of Bcl-2 and PARP cleavage were down-regulated in the *H. pylori*-infected RGM-1 cells ([Fig. 4](#f4-jcp-18-161){ref-type="fig"}). However, the expressions of these proteins were restored with the pretreatment of the polysaccharides from *Artemisia,* MP and MPG6. These results suggest that the polysaccharides from *Artemisia* imposed the cytoprotective effects against apoptotic insults induced by *H. pylori*.

DISCUSSION
==========

This study was designed to determine whether dietary consumption of the polysaccharide fractions from *Artemisia capillaris*, *Panax ginseng* and green tea can inhibit *H. pylori*-induced active inflammation and angiogenesis. We found that the acidic polysaccharides from *Artemisia* significantly attenuated *H. pylori*-induced gastric inflammation as well as apoptosis based on its potential pharmacological actions of anti-inflammation and cytoprotection. Since the ethanol extracts of *Artemisia* are available in clinic for the treatment of gastritis and gastric ulcer, we expect the acidic polysaccharide fraction of Artemisiacan also impose the clinical efficacy supported with the anti-inflammatory mechanisms. Before our study, *Artemisia* extracts had been widely used for the treatment of gynecological disorders, including infertility and dysmenorrhea, which can be commonly caused by endometriosis,[@b15-jcp-18-161] antimicrobial purpose,[@b16-jcp-18-161] increasing anti-nociceptive and antipyretic activities,[@b17-jcp-18-161] improving penile erection,[@b18-jcp-18-161] and treatment of gastritis, gastric ulcer, pancreatitis, and hepatic fibrosis in either western clinic or oriental clinic as well as folk medicine.

In this study, weput hypothesis that the polysaccharides from *Artemisia* can be used for ameliorating gastric inflammation caused by *H. pylori* infection as it efficiently attenuated inflammatory mediator such as COX-2 and iNOS expression. Since effective modulation of inflammation can confer the possibility of cancer prevention in diverse kinds of GI cancers associated with inflammation on their pathogenesis such as chronic atrophic gastritis, chronic reflux esophagitis, cholangitis, pancreatitis, inflammatory bowel disease,[@b19-jcp-18-161] we extended our hypothesis that long-term administration of the polysaccharides from *Artemisia* can provide the hope of chemoprevention of *H. pylori*-associated chronic gastritis. Considering the link between inflammation and carcinogenesis, for instances, the pro-inflammatory enzymes including COX-2 and iNOS have been implicated in carcinogenesis,[@b20-jcp-18-161] continuous administration of the polysaccharides from *Artemisia* lead to safe and efficient achievement of prevention of *H. pylori*-associated gastric tumorigenesis through ameliorating these inflammatory mediators including COX-2. In addition to the anti-inflammatory action of the polysaccharides from *Artemisia* against *H. pylori* infection, we have found additional chemopreventive actions of the polysaccharides from *Artemisia* such as inhibition of angiogenesis with accentuated reduction of VEGF expression since angiogenic growth factors induced by *H. pylori* may play a critical role in the development and progression of gastric cancer[@b21-jcp-18-161] and gastric adenocarcinomas frequently showed high levels of VEGF expression.[@b22-jcp-18-161] According to our previous investigations using cytokine array, basic Fibroblast growth factor (bFGF), intercellular adhesion molecule-1 (ICAM-1, well-known as CD54), Lungkine (CXC-chemokine), Thymus-CK1 (Chemokine ligand 7), TNF-related activation induced cytokine (TRNACE), and TNF-receptor super family cytokine (TROY) levels were all significantly increased with *H. pylori* infection. The genes including bFGF, CD32, CD54, CXC-chemokine, Chemokine ligand 7, TRNACE, and TROY identified with *H. pylori* challenge were all the genes reported to be implicated in stomach carcinogenesis and tumor angiogenesis beyond imflammation.[@b23-jcp-18-161] Real mucosal levels of IL-8, TNF-*α*, IL-1*β*, IL-6, and IL-12 expression, all principally implicated genes in either severe gastritis as well as stomach carcinogenesis.[@b24-jcp-18-161]

Furthermore, the treatment with polysaccharides from *Artemisia* inhibited *H. pylori*-induced apoptosis, in which another pivotal cancer preventive action of the polysaccharides from *Artemisia* was through the inhibition of apoptotic signaling in the gastric mucosal cellsvia the inhibition of caspase-3 and PARP cleavage as well as the recovery of anti-apoptotic molecule Bcl-2. In the development of gastric cancer, *H. pylori* infection induces apoptosis in the mucosa, which further aggravated gastric mucosal damage and perpetuated inflammation.[@b1-jcp-18-161],[@b2-jcp-18-161] In this unpleasant environment relevant to *H. pylori* infection, sodium chloride further cooperates as cancer promoters by enhancing chronic gastric mucosal membrane inflammation and cellular proliferations.[@b25-jcp-18-161] Apoptosis in response to *H. pylori* factors may play an important role in the process by which gastric cancer develops in *H. pylori*-infected humans. The exact mechanisms by which *H. pylori*-associated apoptosis may predispose to gastric cancer are not yet entirely clear, but enhanced rates of cell loss could potentially accelerate the development of gastric atrophy or intestinal metaplasia.[@b26-jcp-18-161]

*H. pylori* show a wide spectrum of different specificities in adhesion to host cells, suggesting a multifactorial adherence. The polysaccharide fraction from *Artemisia* (MP)had reported to show the inhibitory activity with the content of uronic acids, particularly galacturonic acid, reaching approximately 22% in total carbohydrate.[@b9-jcp-18-161] Large amounts of uronic acids were also detected in the acidic polysaccharide fraction isolated from *P. ginseng* (GP).[@b27-jcp-18-161] Thus, we compared the anti-inflammatory activities of MP, GP and the mixture of MP and GP (MPG6) on the damage induced by *H. pylori*. We observed MPG6 have the strong anti-inflammatory effect on the *H. pylori* infection. The carbohydrate components of *Artemisia* and *P. ginseng* may exhibit the synergistic inhibitory effect on the inflammation, adhesion and angiogenesis induced by *H. pylori* in host-bacterial interactions. Therefore, the acidic polysaccharides from *Artemisia* or *P. ginseng* may be useful dietary substances to control *H. pylori*-induced gastric disorders.

This research was supported by High Value-added Food Technology Development Program, iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries; 111121-3), Republic of Korea.

![The polysaccharides from *Artemisia, Panax ginseng* and green tea had no cytotoxicity. GP, MP, MPG6 and GT (0.01, 0.1 or 1 mg/ml) were tested for their cytotoxic activity using the MTT colorimetric assay. The data were presented as mean±SD for three different experiments performed in triplicate.](jcp-18-161f1){#f1-jcp-18-161}

![Inhibitory effects of the polysaccharides on the expression of inflammatory mediators in *H. pylori*-infected gastric epithelial cells. RGM-1 cells were pretreated with polysaccharides (0.1 mg/ml) for 1 h and stimulated with *H. pylori* (10 MOI) for 8 h. Expressions of inflammatory mediator such as COX-2, iNOS and IL-8 (A) and angiogenic markers such as VEGF, HIF-1*α*, PDGF, bFGF, ICAM1 and VCAM (B) were analyzed by RT-PCR. (C) RGM-1 cells were pretreated the polysaccharides GP, MP, MPG6 and GT (0.1 mg/ml) for 1 hour before *H. pylori* stimulation (10 MOI, 24 h) then checked the protein levels of COX-2.](jcp-18-161f2){#f2-jcp-18-161}

![Inhibitory effects of the polysaccharides including *A. capillaris* on the expression of inflammatory mediatorsin *H. pylori*-infected gastric cancer cells. MKN-28 cells were pretreated with polysaccharides (0.1 mg/ml) for 1 h and stimulated with *H. pylori* (10 MOI) for 8 h or 24 h for RT-PCR or Western blotting, respectively. The mRNA expressions of COX-2, IL-8 and HIF-1*α* (A) and the protein levels of COX-2 (B) were measured.](jcp-18-161f3){#f3-jcp-18-161}

![Protective effects of the polysaccharides including *A. capillaris* on the apoptosisin *H. pylori*-infected gastric epithelial cells. The expression of apoptotic markers such as cleaved caspase-3, Bcl-2 and PARP were analyzed by Western blotting. Representative band were shown. Three independent experiments were performed.](jcp-18-161f4){#f4-jcp-18-161}
